clinical trial · NCT06315322
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
UCB Biopharma SRL·phase3·active not recruiting·n = 70
Childhood Absence EpilepsyJuvenile Absence EpilepsyBrivaracetam Film-coated tabletBrivaracetam oral solution
brief summary
The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.
started
Jul 10, 2024
primary completion
Nov 16, 2029
completion
Nov 16, 2029
last updated
Jul 17, 2026
official title
A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol